Form 8-K - Current report:
SEC Accession No. 0001558370-20-013013
Filing Date
2020-11-06
Accepted
2020-11-06 07:00:41
Documents
13
Period of Report
2020-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amph-20201106x8k.htm   iXBRL 8-K 100292
2 EX-99.1 amph-20201106xex99d1.htm EX-99.1 721471
  Complete submission text file 0001558370-20-013013.txt   976919

Data Files

Seq Description Document Type Size
3 EX-101.SCH amph-20201106.xsd EX-101.SCH 3214
4 EX-101.LAB amph-20201106_lab.xml EX-101.LAB 15501
5 EX-101.PRE amph-20201106_pre.xml EX-101.PRE 10525
6 EXTRACTED XBRL INSTANCE DOCUMENT amph-20201106x8k_htm.xml XML 4687
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

EIN.: 330702205 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36509 | Film No.: 201292359
SIC: 2834 Pharmaceutical Preparations